Article

57th ERA-EDTA Congress: Virtual Press Conference on Coronavirus and the Kidneys June 5th

SARS-CoV-2 affects renal function, and some patients have been known to develop acute kidney injury (AKI). Kidney patients are also at greater risk from coronavirus.  On June 5 at 3.30 pm CEST, experts will convene in a special online Zoom session of the ERA-EDTA (European Renal Association and European Dialysis and Transplant Association). to discuss the relationship between coronavirus and kidney function.

tashatuvango@AdobeStock_124119605

SARS-CoV-2 affects renal function, and some patients have been known to develop acute kidney injury (AKI). Kidney patients are also at greater risk from coronavirus.  On June 5 at 3.30 pm CEST, experts will convene in a special online Zoom session of the ERA-EDTA (European Renal Association and European Dialysis and Transplant Association). to discuss the relationship between coronavirus and kidney function. 

The Congress of the ERA-EDTA is Europe´s biggest congress on nephrology and renal replacement therapy. More than 8,000 participants sharing their knowledge and discussing the latest research findings are expected. This year, the Congress will continue as planned from June 6-9, 2020, but in a fully virtual form.

A day before the Congress, on June 5, at 3.30 pm CEST, we extend a cordial invitation to a ZOOM Press Conference on Corona and the Kidneys. Various international experts will report on their experience during the corona crisis and will discuss the latest research findings.

 

Program of the Press Conference

Are dialysis patients at particular risk? The Italian experience
Mario Gennaro Cozzolino

Dialysis and mortality in Spain
Maria Jose Soler Romeo

Prognosis and risk factors for mortality in patients on kidney replacement therapy with COVID-19: The ERACODA Study
Luuk Hilbrands

AKI and ESKD in severe COVID-19: pathology, management, outcome. The German experience
Elion Hoxha (t.b.c.)

To attend the Press Conference, please send an email with your contact details and details of the medium for which you are working to press@era-edta.org. After you register, you will be sent the link to the conference.

ERA-EDTA Press Office

Dr. Bettina Albers
Tel. +49 3643 7764-23
Mobile +49 174 2165629
email: press@era-edta.org

Related Videos
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
Rahul Aggarwal, MD | Credit: LinkedIn
Brendon Neuen, MBBS, PhD | Credit: X.com
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Ralph DeFronzo, MD | Credit: UT San Antonio
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
Atul Malhotra, MD | Credit: Kyle Dykes; UC San Diego Health
Optimizing Diabetes Therapies with New Classifications
© 2024 MJH Life Sciences

All rights reserved.